Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Net Equity Issued and Repurchased (2009 - 2026)

Updated

Vistagen Therapeutics (VTGN) posted Net Equity Issued and Repurchased of $351,000 for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 98.7% from $27.93 million a year earlier and down 65.1% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Net Equity Issued and Repurchased at Vistagen Therapeutics was -$27.12 million; for FY2026 (ended Mar 31, 2026), it came in at $8,000.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -77.2% (FY2021 to FY2026).
  • In prior fiscal years, Vistagen Therapeutics' Net Equity Issued and Repurchased was $93.45 million in FY2024 and $239,400 in FY2022 (-98.2%).
  • Quarterly Net Equity Issued and Repurchased has run from a low of -$36.31 million in fiscal Q4 2024 to a high of $93.73 million in fiscal Q3 2024 over five years.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in three of the last five quarters, with growth averaging 104.2%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior fiscal quarters was $1.01 million (Q1 2027), -$30.87 million (Q4 2026) and $2.39 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 50,000.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -377.00 Mn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn -966.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -5.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -406.00 Mn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -283.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 351,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 351,000.00
Jun 30, 2026 1.01 Mn
Mar 31, 2026 -30.87 Mn
Dec 31, 2025 2.39 Mn
Sep 30, 2025 27.93 Mn
Jun 30, 2025 558,000.00
Mar 31, 2025 -1.26 Mn
Dec 31, 2024 1.17 Mn
Jun 30, 2024 88,000.00
Mar 31, 2024 -36.31 Mn
Dec 31, 2023 93.73 Mn
Sep 30, 2023 937,000.00
Sep 30, 2022 -51,700.00
Jun 30, 2022 156,100.00
Mar 31, 2022 123,400.00
Dec 31, 2021 58,000.00
Sep 30, 2021 13,500.00
Jun 30, 2021 44,500.00
Mar 31, 2021 -17,100.00
Dec 31, 2020 13,600.00
API Access

Vistagen Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VTGN&period=max&api_key=YOUR_API_KEY